Atlas Trials

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Clinical trial NCT01511536 · COMPLETED

Trial details

NCT number
NCT01511536
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2012-03-01
Primary completion
2014-07-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.